Evidence map›Paper›PMID 37071333›Full record

ArticleAIDS and behavior2023

Rapid or Immediate ART, HIV Stigma, Medical Mistrust, and Retention in Care: An Exploratory Mixed Methods Pilot Study.

Ofole Mgbako, Claire Loughran, Rachel Mathu, Delivette Castor, Jacob McLean, Magdalena E Sobieszczyk, Susan Olender, Peter Gordon, Javier Lopez-Rios, Robert H Remien

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Effective Messages to Reduce Stigma among People Newly Diagnosed with HIV during Rapid ART Initiation.International journal of environmental research and public health · 2024
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ofole MgbakoDivision of Infectious Diseases and Immunology, Department of Internal Medicine, NYU Langone Health, New York, NY, USA. Ofole.mgbako@nyulangone.org.ORCID http://orcid.org/0000-0002-8955-4303
Claire LoughranNewYork Presbyterian, Columbia University Irving Medical Center, New York, NY, USA.
Rachel MathuICAP, Columbia University Mailman School of Public Health, New York, NY, USA.
Delivette CastorDivision of Infectious Disease, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Jacob McLeanDivision of Infectious Disease, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Magdalena E SobieszczykDivision of Infectious Disease, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Susan OlenderDivision of Infectious Disease, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Peter GordonDivision of Infectious Disease, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Javier Lopez-RiosDepartment of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
Robert H RemienHIV Center for Clinical and Behavioral Studies, NY State Psychiatric Institute and Columbia University, New York, NY, USA.
Columbia University Irving Medical Center · USColumbia University · USDrexel University · USNew York City Health and Hospitals Corporation · USNew York Psychoanalytic Society and Institute · US

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Columbia Collaborative HIV/AIDS Clinical Trials UnitU01AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HAMMER, SCOTT M · 2007 to 2011
$15.4M
INSPIRE : Interdisciplinary Social and Behavioral Science Prevention and Intervention REsearch in HIVT32MH019139 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Claude Ann Mellins, Jae M. Sevelius · 1989 to 2026
$10.8M
Columbia Integrated Training Program in Infectious Diseases ResearchT32AI100852 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK, Anne-Catrin Uhlemann · 2013 to 2026
$2.2M
NIAID NIH HHS T32 AI100852NIAID NIH HHS U01 AI069470NIAID NIH HHS UM1 AI069470NIMH NIH HHS P30MH43520NIMH NIH HHS T32 MH019139NIMH NIH HHS T32MH019139
6 · The paper itself

Abstract

Rapid or immediate antiretroviral therapy (iART) after HIV diagnosis improves linkage to care and time to viral suppression. However, iART may affect or be affected by HIV-related stigma and medical mistrust. In this mixed-methods pilot study, we examined the bi-directional role of HIV stigma, medical mistrust, and visit adherence (VA) in the context of iART in a diverse, newly diagnosed patient population. Participants were recruited from an HIV clinic in New York City and we utilized a convergent parallel design integrating quantitative data from demographic surveys, the HIV Stigma Survey (HIVSS), the Medical Mistrust Index (MMI) and electronic medical records, and qualitative data from in-depth interviews. Among the sample (N = 30), 26% (N = 8) initiated ART same-day or within 3 days, while the majority (N = 17) initiated between 4 and 30 days, and 17% (N = 5) initiated ART > 30 days. The median (range) age was 35, and most were English-speaking, Black or Hispanic men and identified as gay. Time to ART initiation was associated with time to linkage to care and time to viral suppression. Day 0-3 group's major theme was iART as stigma prevention, and they had the highest mean HIVSS, lowest MMI score, and a visit adherence of 0.86. Day 4-30 group's major theme was alleviation of internalized stigma, and they had the lowest mean HIVSS score, and highest visit adherence of 0.91. Day > 30 group's major theme was exacerbation of perceived or anticipated stigma, had the highest MMI score and a visit adherence of 0.85. iART implementation requires equitable strategies that address HIV-stigma and mistrust.

Indexed as

HIV InfectionsRetention in CareHIVHumansMalePilot ProjectsTrustHIVImmediate ARTMedical mistrustRapid ARTRetention in careStigma

Identifiers

PMID37071333
PMCPMC10111080
OpenAlexW4366238478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.